Pre-made Benralizumab benchmark antibody ( Whole mAb, anti-IL5RA therapeutic antibody, Anti-CD125/CDw125/HSIL5R3/IL5R Antibody) for drug discovery and mechanism of action (MOA) research

Cat:GMP-Bios-ab-058

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

SKU GMP-Bios-ab-058 Category Tag

Product Details

Pre-Made Benralizumab biosimilar, Whole mAb, Anti-IL5RA Antibody: Anti-CD125/CDw125/HSIL5R3/IL5R therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Benralizumab, sold under the brand name Fasenra, is a monoclonal antibody medication which is developed by MedImmune for the treatment of asthma. It is directed against the alpha-chain of the interleukin-5 receptor (CD125).[2][3]

Products Name (INN Index)

Pre-Made Benralizumab biosimilar, Whole mAb, Anti-IL5RA Antibody: Anti-CD125/CDw125/HSIL5R3/IL5R therapeutic antibody

INN Name

Benralizumab

Target

IL5RA

Format

Whole mAb

Derivation

Humanized

Species Reactivity

Human

CH1 Isotype

IgG1

VD LC

Kappa

Highest_Clin_Trial (Jan '20)

Approved

Est. Status

Active

100% SI Structure

None

99% SI Structure

None

95-98% SI Structure

None

Year Proposed

2009

Companies

AstraZeneca,Cincinnati Children's Hospital Medical Center,Kyowa Hakko,Kyowa Hakko Kirin,McMaster University,MedImmune,National Jewish Medical and Research Center,BioWa

Conditions Approved

Asthma

Conditions Active

Chronic obstructive pulmonary disease,Nasal polyps,Atopic dermatitis,Churg-Strauss syndrome,Hypereosinophilic syndrome,Rhinosinusitis,Eosinophilic gastroenteritis

Conditions Discontinued

Skin disorders

Development Tech

POTELLIGENT Technology

Previous Name

NA

Gm Offical Target Name

IL5RA

Package

, ,

Genemeidi Omicron Variant Products
test
Previous slide
Next slide